Participants’ criteria | All participants n = 78 (100%) | Malignant PVT n = 61 (78.2%) | Benign PVT n = 17 (21.8%) | Sig | ||||
---|---|---|---|---|---|---|---|---|
Demographic criteria | ||||||||
Age (ys) | Median (IQR) | 60 | (12) | 60 | (12) | 62 | (16) | 0.716 |
Sex | ||||||||
Male | Count (%) | 45 | (57.7%) | 34 | (55.7%) | 11 | (64.7%) | 0.508 |
Female | Count (%) | 33 | (42.3%) | 27 | (44.3%) | 6 | (35.3%) | |
Liver functions | ||||||||
ALT (IU/L) | Median (IQR) | 41 | (17) | 41 | (17) | 40 | (12) | 0.611 |
AST (IU/L) | Median (IQR) | 46 | (16) | 48 | (14) | 43 | (13) | 0.085 |
Serum albumin (gm/dl) | Median (IQR) | 2.9 | (0.6) | 2.9 | (0.7) | 2.7 | (0.5) | 0.468 |
Serum bilirubin (mg/dl) | Median (IQR) | 1.9 | (0.5) | 1.8 | (0.6) | 1.9 | (0.6) | 0.258 |
INR | Median (IQR) | 1.8 | (0.2) | 1.8 | (0.2) | 1.9 | (0.4) | 0.201 |
Child–Pugh grade | ||||||||
A | Count (%) | 8 | (10.3%) | 7 | (11.5%) | 1 | (5.9%) | 0.128 |
B | Count (%) | 52 | (66.7%) | 43 | (70.5%) | 9 | (52.9%) | |
C | Count (%) | 18 | (23.1%) | 11 | (18%) | 7 | (41.2%) | |
Other laboratory parameters | ||||||||
Hemoglobin (g/dl) | Median (IQR) | 11.7 | (1.6) | 11.7 | (1.7) | 11.6 | (1.4) | 0.904 |
White blood cells (× 103/mm3) | Median (IQR) | 6.4 | (3.7) | 5.9 | (3.2) | 7.9 | (4.6) | 0.145 |
Platelets (× 103/mm3) | Median (IQR) | 123 | (35) | 123 | (33) | 115 | (59) | 0.712 |
Serum creatinine (mg/dl) | Median (IQR) | 1.0 | (0.2) | 1.1 | (0.1) | 1 | (0.2) | 0.236 |
Criteria related to HCC | ||||||||
HCC focality | ||||||||
Multifocal | Count (%) | 45 | (57.7%) | 39 | (63.9%) | 6 | (35.3%) | 0.035 |
Unifocal | Count (%) | 33 | (42.3%) | 22 | (36.1%) | 11 | (64.7%) | |
HCC size (cm) | Median (IQR) | 5.4 | (2.1) | 5.6 | (2.4) | 4.5 | (1.3) | 0.000 |
AFP (ngm/ml) | Median (IQR) | 215 | (521) | 323 | (630) | 21 | (60) | 0.000 |
Criteria related PVT | ||||||||
PVD (mm) | Median (IQR) | 18 | (5) | 19 | (5) | 14 | (3) | 0.000 |
SWE (kps) | Median (IQR) | 20.8 | (13.7) | 22.7 | (9.1) | 8.2 | (3.5) | 0.000 |